van der heijde

  publications on imaging

 

 complete list

  landewé

    publications on imaging

 

 complete list


.
IMAGING | RHEUMATOLOGY | INTERNATIONAL
.

 

home

 

company

 

van der heijde

 

landewé

publications

 

projects

 

contact

 

 

.


thesis

 

 

 
1991

Disease activity and outcome in rheumatoid arthritis:
a
methodological study.

  Katholieke Universiteit Nijmegen 8 march 1991

 

 

 

.


scientific international papers in relation to imaging

 

 

 
2015  

van den Berg R, de Hooge M, Bakker PA, van Gaalen F, Navarro-Compán V, Fagerli KM, Landewé R, van Oosterhout M, Ramonda R, Reijnierse M, van der Heijde D. Metric Properties of the SPARCC Score of the Sacroiliac Joints - Data from Baseline, 3-month, and 12-month Followup in the SPACE Cohort.
J Rheumatol. 2015 May 1. pii: jrheum.140806. [Epub ahead of print].

 
2015  

de Bruin F, Ter Horst S, van den Berg R, de Hooge M, van Gaalen F, Fagerli KM, Landewé R, van Oosterhout M, Bloem JL, van der Heijde D, Reijnierse M. Signal intensity loss of the intervertebral discs in the cervical spine of young patients on fluid sensitive sequences.
Skeletal Radiol. 2015 Dec 4. [Epub ahead of print]

 
2015  

de Bruin F, Ter Horst S, Bloem HL, van den Berg R, de Hooge M, van Gaalen F, Fagerli KM, Landewé R, van Oosterhout M, van der Heijde D, Reijnierse M. Prevalence of degenerative changes of the spine on magnetic resonance images and radiographs in patients aged 16-45 years with chronic back pain of short duration in the Spondyloarthritis Caught Early (SPACE) cohort.
Rheumatology (Oxford). 2015 Aug 14. pii: kev283. [Epub ahead of print]

 
2015  

van der Heijde D, Breban M, Halter D, DiVittorio G, Bratt J, Cantini F, Kary S, Pangan AL, Kupper H, Rathmann SS, Sieper J, Mease PJ. Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab.
Rheumatology doi:10.1093/rheumatology/keu438

 
2015  

Kortekaas MC, Kwok WY, Reijnierse M, Wolterbeek R, Bøyesen P, van der Heijde D, Bloem JL, Kloppenburg M. Magnetic Resonance Imaging in Hand Osteoarthritis: Intraobserver Reliability and Criterion Validity for Clinical and Structural Characteristics.
J Rheumatol 2015 May 15;():Other

 
2015  

Aga A-B, Hammer HB, Olsen IC, Uhlig T, Kvien TK, van der Heijde D, Fremstad H, Madland TM, Lexberg ÅS, Haukeland H, Rødevand E, Høili C, Stray H, Bendvold AN, Soldal DM, Bakland G, Lie E, Haavardsholm EA. First step in the development of an ultrasound joint inflammation score for rheumatoid arthritis using a data-driven approach.
Ann Rheum Dis 2015 online

 
2015  

MaksymowychWP, Dougados M, van der Heijde D, Sieper J, Braun J, Citera G, Van den Bosch F, Logeart I, Wajdula J, Jones H, Marshall L, Bonin R, Pedersen R, Vlahos B, Kotak S, Bukowski JF. Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study.
Ann Rheum Dis Published 12 August 2015, doi:10.1136/annrheumdis-2015-207596

 
2015  

de Hooge M, van den Berg R, Navarro-Compán V, Reijnierse M, van Gaalen F, Fagerli K, Landewé R, van Oosterhout M, Ramonda R, Huizinga T, van der Heijde D. Patients with chronic back pain of short duration from the SPACE cohort: which MRI structural lesions in the sacroiliac joints and inflammatory and structural lesions in the spine are most specific for axial spondyloarthritis?
Ann Rheum Dis Published 18 August 2015, doi:10.1136/annrheumdis-2015-207823

 
2015  

Navarro-Compán V, Ramiro S, Landewé R, Dougados M, Miceli-Richard C, Richette P, van der Heijde D. Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohort.
Ann Rheum Dis Published 24 September 2015, doi:10.1136/annrheumdis-2015-207786

 
2015  

Machado PM, Baraliakos X, van der Heijde D, Braun J, Landewé R. MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis. Ann Rheum Dis Published 13 October 2015, doi:10.1136/annrheumdis-2015-208011

 
2015  

Takeuchi T, Tanaka Y, Ishiguro N, Yamanaka H, Yoneda T, Ohira T, Okubo N, Genant HK, van der Heijde D. Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose–response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)—a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial.
Ann Rheum Dis Published 19 November 2015, doi:10.1136/annrheumdis-2015-208052

 
2015  

Huo Y, De Hair MJH, Shaib YO, van der Heijde D, Kuchuk NO, Viergever MA, van Laar JM, Vincken KL, FP Lafeber. Computerised versus conventional methodology of radiographic joint destruction assessment in early rheumatoid arthritis.
RMD Open 2015; 1:e000148, doi:10.1136/rmdopen-2015-000148

 
2015  

Haugen IK, Slatkowsky Christensen B, Bøyesen P, Sesseng S, van der Heijde D, Kvien TK. Increasing synovitis and bone marrow lesions are associated with incident joint tenderness in hand osteoarthritis.
Ann Rheum Dis 2015;75:117-23

 
2015  

Atsumi T, Yamamoto K, Takeuchi T, Yamanaka H, Ishiguro N, Tanaka Y, Eguchi K, Watanabe A, Origasa H, Yasuda S, Yamanishi Y, Kita Y, Matsubara T, Iwamoto M, Shoji T, Okada T, van der Heijde D, Miyasaka N, Koike T. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.
Ann Rheum Dis 2015;75:75-83

 
2015  

Danila MI, Westfall AO, Raman K, Chen L, Reynolds RJ, Hughes LB, Arnett DK, McGwin G, Szalai AJ, van der Heijde DM, Conn D, Callahan LF, Moreland LW, Bridges Jr SL. The role of genetic variants in CRP in radiographic severity in African Americans with early and established rheumatoid arthritis.
Genes and Immunity 2015;16:446-51

 
2015  

Sieper J, van der Heijde D, Dougados M, Maksymowych WP, Scott BB, Boice JA, Berd Y, Bergman G, Curtis S, Tzontcheva A, Huyck S, Weng HH. A Randomized, Double-Blind, Placebo-Controlled, Sixteen-Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis.
Arthritis Rheum 2015;67:2702–12

 
2015  

van den Berg R, Lenczner G, Thévenin F, Claudepierre P, Feydy A, Reijnierse M, Saraux A, Rahmouni A, Dougados M, van der Heijde D. Classification of axial SpA based on positive imaging (radiographs and/or MRI of the sacroiliac joints) by local rheumatologists or radiologists versus central trained readers in the DESIR cohort.
Ann Rheum Dis 2015;74:2016-21

 
2015  

Navarro-Compán V, de Miguel E, van der Heijde D, Landewé R, Almodóvar R, Montilla C, Beltrán E, Zarco P. Sponyloarthritis features forecasting the presence of HLA-B27 or sacroiliitis on magnetic resonance imaging in patients with suspected axial spondyloarthritis: Results from a cross-sectional study in the ESPeranza Cohor.
Arthritis Res Ther 2015;17:265

 
2015  

Mease PJ, McInnes IB, Kirkham B, Kavanaugh A, Rahman P, van der Heijde D, Landewé R, Nash P, Pricop L, Yuan J, Richards HB, Mpofu S, for the FUTURE 1 Study Group. Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis.
N Engl J Med 2015;373:1329-39

 
2015  

Smolen JS, van Vollenhoven R, Kavanaugh A, Strand V, Vencovsky J, Schiff M, Landewé R, Haraoui B, Arendt C, Mountian I, Carter D, van der Heijde D. Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients.
Arthritis Res Ther 2015;17:art no 245

 
2015  

Ramiro S, Landewé R, van Tubergen A, Boonen A, Stolwijk C, Dougados M, van den Bosch F, van der Heijde D. Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis.
RMD Open 2015;1:e000153, doi:10.1136/rmdopen-2015-000153

 
2015  

Mangnus L, van Steenbergen HW, Lindqvist E, Brouwer E, Reijnierse M, Huizinga TWJ, Gregersen PK, Berglin E, Rantapää-Dahlqvist S, van der Heijde D, van der Helm-van Mil, A.H.M. Studies on ageing and the severity of radiographic joint damage in rheumatoid arthritis.
Arthritis Res Ther 2015;17:art no 222

 
2015  

Barnabe C, Sun Y, Boire G, Hitchon CA, Haraoui B, Carter Thorne J, Tin D, van der Heijde D, Curtis JR, Jamal S, Pope JE, Keystone EC, Bartlett S, Bykerk VP, CATCH Investigators. Heterogeneous Disease Trajectories Explain Variable Radiographic, Function and Quality of Life Outcomes in the Canadian Early Arthritis Cohort (CATCH).
PLoS ONE 10(8): e0135327

 
2015  

Magnusson K, Slatkowsky-Christensen B, van der Heijde D, Kvien TK, Hagen KB, Haugen IK. Body mass index and progressive hand osteoarthritis: Data from the Oslo hand osteoarthritis cohort.
Scand J Rheumatol 2015;44:331-6

 
2015  

Mease P, Deodhar A, Fleischmann R, Wollenhaupt J, Gladman D, Leszczyński P, Vitek P, Turkiewicz A, Khraishi M, FitzGerald O, Landewé R, de Longueville M, Hoepken B, Peterson L, van der Heijde D. Effect of certolizumab pegol over 96 weeks in patients with psoriatic arthritis with and without prior antitumour necrosis factor exposure.
RMD Open 2015;1:e000119.doi:10.1136/rmdopen-2015-000119

 
2015  

Mandl P, Navarro-Compán V, Terslev L, Aegerter P, van der Heijde D, D'Agostino MA, Baraliakos X, Pedersen SJ, Jurik AG, Naredo E, Schueller-Weidekamm C, Weber U, Wick MC, Bakker PAC, Filippucci E, Conaghan PG, Rudwaleit M, Schett G, Sieper J, Tarp S, Marzo-Ortega H, Østergaard M. EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice.
Ann Rheum Dis 2015;74:1327-39

 
2015  

Genovese MC, Fleischmann R, Kivitz AJ, Rell-Bakalarska M, Martincova R, Fiore S, Rohane P, van Hoogstraten H, Garg A, Fan C, van Adelsberg J, Weinstein SP, Graham NMH, Stahl N, Yancopoulos G, Huizinga TWJ, van der Heijde D. Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study.
Arthritis Rheumatol 2015;67:1424–37

 
2015  

Landewé R Smolen JS, Florentinus S, Chen S, Guérette B, van der Heijde D. Existing joint erosions increase the risk of joint space narrowing independently of clinical synovitis in patients with early rheumatoid arthritis.
Arthritis Res Ther 2015;17:133

 
2015  

Navarro-Compán V, Gherghe AM, Smolen JS, Aletaha D, Landewé R, van der Heijde D. Relationship between disease activity indices and their individual components and radiographic progression in RA: a systematic literature review.
Rheumatology 2015;54:83-90

 
2015  

Hemke R, Nusman CM, van der Heijde DMFM, Doria AS, Kuijpers TW, Maas M, van Rossum MAJ. Frequency of joint involvement in juvenile idiopathic arthritis during a 5‐year follow‐up of newly diagnosed patients: implications for MR imaging as outcome measure.
Rheumatol Int 2015;35:351-7

 
2015  

Stomp W, Krabben A, van der Heijde D, Huizinga TWJ, Bloem JL, Østergaard M, van der Helm-van Mil, AHM, Reijnierse M. Aiming for a simpler early arthritis MRI protocol: can Gd contrast administration be eliminated?
European Radiology 2015;25:1520-7

 
2015  

Nieuwenhuis WP, Krabben A, Stomp W, Huizinga TWJ, van der Heijde D, Bloem JL, van der Helm-van Mil AHM, Reijnierse M. Evaluation of Magnetic Resonance Imaging–Detected Tenosynovitis in the Hand and Wrist in Early Arthritis.
Arthritis Rheumatol 2015;67:869–76

 
2015  

van Onna M, van Tubergen A, Jurik A, van der Heijde D, Landewé R. Natural course of bone marrow oedema on magnetic resonance imaging of the sacroiliac joints in patients with early inflammatory back pain: a 2-year follow-up study.
Scand J Rheumatol 2015;44:129-34

 
2015  

Sieper J, Landewé R, Rudwaleit M, van der Heijde D, Dougados M, Mease PJ, Braun J, Deodhar A, Kivitz A, Walsh J, Hoepken B, Nurminen T, Maksymowych WP. Effect of Certolizumab Pegol over 96 Weeks in Patients with Axial Spondyloarthritis: Results from a Phase 3 Randomized Trial.
Arthritis Rheumatol 2015;67:668-77

 
2015  

Deodhar A, Braun J, Inman RD, van der Heijde D, Zhou Y, Xu S, Han C, Hsu B. Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study
Ann Rheum Dis 2015;74:757-61

 
2015  

Moltó A, Paternotte S, van der Heijde D, Claudepierre P, Rudwaleit M, Dougados M. Evaluation of the validity of the different arms of the ASAS set of criteria for axial spondyloarthritis and description of the
different imaging abnormalities suggestive of spondyloarthritis: data from the DESIR cohort.
Ann Rheum Dis 2015;74:746-51

 
2015  

Krabben A, Stomp W, Huizinga TWJ, van der Heijde D, Bloem JL, Reijnierse M, van der Helm-van Mil AHM. Concordance between inflammation at physical examination and on MRI in patients with early arthritis.
Ann Rheum Dis 2015; 74:506-512

 
2015  

Landewé R, Østergaard M, Keystone EC, Florentinus S, Liu S, van der Heijde D. Analysis of integrated radiographic data from two long-term, open-label extension studies of adalimumab for the treatment of rheumatoid arthritis.
Arthritis Care Res 2015;2:108-6

 
2015  

Navarro-Compàn V, Landewé R, Provan SA, Ødegard S, Uhlig T, Kvien TK, Keszei AP, Ramiro S, van der Heijde D. Relationship between types of radiographic damage and disability in patients with rheumatoid arthritis in the EURIDISS cohort: a longitudinal study.
Rheumatology 2015;54:83-90

 
2015  

Ramiro S, Stolwijk C, van Tubergen A, van der Heijde D, Dougados M, van den Bosch F, Landewé R.
Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study.
Ann Rheum Dis 2015;74:52-9

 
     
2014  

Haugen IK, Slatkowsky-Christensen B, Bøyesen P, Sesseng S, van der Heijde D, Kvien TK. MRI findings predict radiographic progression and development of erosions in hand osteoarthritis.
Ann Rheum Dis Published 9 September 2014, doi:10.1136/annrheumdis-2014-205949

 
2014  

Stomp W, Krabben A, van der Heijde D, Huizinga TW, Bloem JL, van der Helm-van Mil AH, Reijnierse M. Are rheumatoid arthritis patients discernible from other early arthritis patients using 1.5T extremity magnetic resonance imaging? A large cross-sectional study
J Rheumatol 2014;41:1630-7

 
2014  

Ramiro S, van der Heijde D, van Tubergen A, Stolwijk C, Dougados M, van den Bosch F, Landewé R.
Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort.
Ann Rheum Dis. 2014;73:1455-61

 
2014  

Hemke R, Doria AS, Tzaribachev N, Maas M, van der Heijde DM, van Rossum MA. Selecting Magnetic Resonance Imaging (MRI) Outcome Measures for Juvenile Idiopathic Arthritis (JIA) Clinical Trials: First Report of the MRI in JIA Special Interest Group.
J Rheumatol 2014;41:354-8

 
2014  

Baraliakos X, Heldmann F, Callhoff J, Listing J, Appelboom T, Brandt J, Van den Bosch F, Breban M, Burmester GR, Dougados M, Emery P, Gaston H, Grunke M, van der Horst-Bruinsma IE, Landewé R, Leirisalo-Repo M, Sieper J, De Vlam K, Pappas D, Kiltz U, van der Heijde D, Braun J. Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography.
Ann Rheum Dis 2014;73:1819-25

 
2014  

Nieuwenhuis WP, van Nies JA, Reijnierse M, van der Heijde D, van der Helm-Van Mil AH. Is the modified disease activity score superior to the disease activity score in early arthritis and rheumatoid arthritis? Comment on the article by Baker et al.

Arthritis Rheumatol. 2014;66:3244-5

 
2014  

Visser AW, Bøyesen P, Haugen IK, Schoones JW, van der Heijde DM, Rosendaal FR, Kloppenburg M. Radiographic scoring methods in hand osteoarthritis - a systematic literature search and descriptive review.
Osteoarthritis Cartilage 2014;22:1710-23

 
2014  

Keystone E, Landewé, van Vollenhoven R, Combe B, Strand V, Mease P, Shaughnessy L, VanLunen B, van der Heijde D. Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension.

Ann Rheum Dis 2014; 73:2094-100
 
2014  

Krabben A, Stomp W, van Nies JAB, Huizinga TWJ, van der Heijde D, Bloem JL, Reijnierse M, van der Helm-van Mil AHM. MRI-detected subclinical joint inflammation is associated with radiographic progression.  
Ann Rheum Dis 2014;73:2034-7

 
2014  

Ramiro S, van Tubergen A, van der Heijde D, Stolwijk C, Bookelman G, Dougados M, van den Bosch  F, Landewé RBM. Erosions and sclerosis on radiographs precede the subsequent development of syndesmophytes at the same site: a twelve-year prospective followup of patients with ankylosing spondylitis.
Arthritis Rheumatology 2014;66:2773–2779

 
2014  

van den Berg R, Lenczner G, Feydy A, van der Heijde D, Reijnierse M, Saraux A, Rahmouni A, Dougados M, Claudepierre P. Reading of sacroiliac joints on plain pelvic radiographs: Agreement between clinical practice and trained central reading. Results of the DESIR-cohort.
Arthritis Rheumatol 2014;66:2403-11

 
2014  

Stomp W, Krabben A, van der Heijde D, Huizinga TWJ, Bloem JL, van der Helm-van Mil AHM, Reijnierse M. Aiming for a shorter rheumatoid arthritis MRI protocol: can contrast-enhanced MRI replace T2 for the detection of bone marrow oedema?
Eur Radiol 2014;24:2614-22

 
2014  

Yamamoto K, Takeuchi T, Yamanaka H, Ishiguro N, Tanaka Y, Eguchi K, Watanabe A, Origasa H, Iwai K, Sakamaki Y, van der Heijde D, Miyasaka N, Koike T. Efficacy and safety of certolizumab pegol without methotrexate co-adminstration in Japanese patients with active rheumatoid arthritis: the HIKARI randomized, placebo-controlled trial.

Mod Rheumatol 2014;24:715-24

 
2014  

Hafström I, Engvall I-L, Rönnelid J, Boonen A, van der Heijde D, Svensson B. Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: A randomised study.
BMJ Open 2014;4:e005246

 
2014  

Kavanaugh A, McInnes IB, Mease P, Krueger GG, Gladman D, van der Heijde D, Zhou Y, Lu J, Leu JH, Goldstein N, Beutler A. Clinical efficacy, radiographic and safety findings  through 5years of subcutaneous golimumab treatment in patients with  active psoriatic arthritis: results from a long-term extension of a  randomised, placebo-controlled trial, the GO-REVEAL study).

Ann Rheum Dis 2014:73:1689-94

 
2014  

Dougados M, van der Heijde D, Sieper J, Braun J, Maksymowych WP, Citera G, Miceli-Richard C, Wei JC, Pedersen R, Bonin R, Rahman MU, Logeart I, Wajdula J, Koenig AS, Vlahos B, Alvarez D, Bukowski JF. Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial.

Arthritis Rheumatol. 2014 Aug;66(8):2091-102

 
2014  

van Gaalen FA, Bakker PAC, de Hooge M, Schoones JW, van der Heijde D. Assessment of sacroiliitis by radiographs and MRI: Where are we now?

Curr Opin Rheum 2014;26:384-8

 
2014  

van Onna M, van Tubergen A, van der Heijde DM, Jurik AG, Landewé R. Bone Marrow Edema on Magnetic Resonance Imaging (MRI) of the Sacroiliac Joints Is Associated with Development of Fatty Lesions on MRI over a 1-year Interval in Patients with Early Inflammatory Low Back Pain: A 2-year Followup Study.

J Rheumatol 2014;41:1088-94

 
2014  

de Rooy DPC, van Nies JAB, Kapetanovic MC, Kristjansdottir H, Andersson MLE, Forslind K, van der Heijde DMFM, Gregersen PK, Lindqvist E, Huizinga TWJ, Gröndal G, Svensson B, van der Helm-van Mil AHM. Smoking as a risk factor for the radiological severity of rheumatoid arthritis: a study on six cohorts.

Ann Rheum Dis 2014; 73:1384-7

 
2014  

Maksymowych WP, van der Heijde D, Allaart CF, Landewé R, Boire G, Tak PP, Gui Y, Ghahary A, Kilani R, Marotta A. 14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage.
Arthritis Res Ther 2014;16:R99

 
2014  

Braun J, Baraliakos X, Hermann K-GA, Deodhar A, van der Heijde D, Inman R, Beutler A, Zhou Y, Xu S, Hsu B. The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial.

Ann Rheum Dis 2014;73:1107-13

 
2014  

Navarro-Compán V, van der Heijde D, Ahmad HA, Miller CG, Wolterbeek R, Landewé R. Measurement error in the assessment of radiographic progression in rheumatoid arthritis (RA) clinical trials: the smallest detectable change (SDC) revisited.

Ann Rheum Dis 2014;73:1067-70

 
2014  

Nam JL, Villeneuve E, Hensor EMA, Wakefield RJ, Conaghan PG, Green MJ, Gough A, Quinn M, Reece R, Cox SR, Buch MH, van der Heijde DM, Emery P. A randomised controlled trial of etanercept and  methotrexate to induce remission in early inflammatory arthritis: the  EMPIRE trial.  

Ann Rheum Dis 2014;73:1027-36

 
2014  

van Onna M, van Tubergen A, van der Heijde D, Jurik AG, Landewé R. Gadolinium contrast-enhanced MRI sequence does not have an incremental value in the assessment of sacroiliitis in patients with early inflammatory back pain by using MRI in combination with pelvic radiographs: a 2-year follow-up study.

Clin Exp Rheumatol 2014;32:225-30

 
2014  

van der Heijde D, Sieper J, Maksymowych W, Brown M, Lambert R, Rathmann S, Pangal A. Spinal inflammation in the absence of sacroiliac joint inflammation on MRI in patients with active non-radiographic axial spondyloarthritis.

Arthritis Rheum 2014;66:667-73

 
2014  

Hemke R, Doria AS, Tzaribachev N, Maas M, van der Heijde DM, van Rossum MA. Selecting Magnetic Resonance Imaging (MRI) Outcome Measures for Juvenile Idiopathic Arthritis (JIA) Clinical Trials: First Report of the MRI in JIA Special Interest Group.
J Rheumatol 2014;41:354-8

 
2014  

Kroon FPB, van der Burg LRA, Ramiro S, Landewé RBM, Buchbinder R, van der Heijde D. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis) (Protocol).

Cochrane Database of Systematic Reviews 2014;1:CD010952. DOI: 10.1002/14651858.CD010952

 
2014  

van Tuyl LHD, van der Heijde D, Knol DL, Boers M. Chronological reading of radiographs in rheumatoid arthritis increases efficiency and does not lead to bias.

Ann Rheum Dis 2014;73:391-5

 
2014  

Landewé R, Braun J, Deodhar A, Dougados M, Maksymowych WP, Mease PJ, Reveille JD, Rudwaleit M, van der Heijde D, Stach C, Hoepken B, Fichtner A, Coteur G, de Longueville M, Sieper J. Efficacy of Certolizumab Pegol on Signs and Symptoms of Axial Spondyloarthritis including Ankylosing Spondylitis: 24 Week Results of a Double-Blind Randomized Placebo-Controlled Phase 3 Study.
Ann Rheum Dis 2014;73:39-47

 
2014  

Schiff M, Weinblatt ME, Valente R, van der Heijde D, Citera G, Elegbe A, Maldonado M, Fleischmann R. Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial.
Ann Rheum Dis 2014;73:86-94

 
2014  

Mease PJ, Fleischmann R, Deodhar AA, Wollenhaupt J, Khraishi M, Kielar D, Woltering F, Stach C, Hoepken B, Arledge T, van der Heijde D. Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA).
Ann Rheum Dis 2014;73:48-55

 
2014  

van der Heijde D, Fleischmann R, Wollenhaupt J, Deodhar AA, Kielar D, Woltering F, Stach C, Hoepken B, Arledge T Mease PJ. Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol.
Ann Rheum Dis 2014;73:233-7

 
2014  

Nam JL, Villeneuve E, Hensor EMA, Conaghan PG, Keen HI, Buch MH, Gough AK, Green MJ, Helliwell PS, Keenan AM, Morgan AW, Quinn M, Reece R, van der Heijde DM, Wakefield RJ, Emery P. Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study).
Ann Rheum Dis 2014;73:75-85

 
2014  

Knevel R, Tsonaka R, Le Cessie S, van der Linden M, Huizinga T, van der Heijde D, Houwing-Duistermaat J, van der Helm-van Mil A. Comparison of methodologies for analysing the progression of joint destruction in rheumatoid arthritis.
Scand J Rheumatol 2014;42:182-9

 
2014  

Keystone EC, van der Heijde D, Kavanaugh A, Kupper H, Liu S, Guérette B, Mozaffarian N. Clinical, functional, and radiographic benefits fo longterm adalimumab plus methotrexate: final 10-year data in longstanding rheumatoid arthritis.
J Rheumatol 2014;40:1487-97

 
2014  

Haugen I, Slatkowsky-Christensen B, Bøyesen P, van der Heijde D, Kvien T. Cross-sectional and longitudinal associations between radiographic features and measures of pain and physical function in hand osteoarthritis.
Osteoarthritis Cartilage 2014;21:1191-8

 
     
2013  

Yamamoto K, Takeuchi T, Yamanaka H, Ishiguro N, Tanaka Y, Eguchi K, Watanabe A, Origasa H, Iwai K, Sakamaki Y, van der Heijde D, Miyasaka N, Koike T. Efficacy and safety of certolizumab pegol without methotrexate co-adminstration in Japanese patients with active rheumatoid arthritis: the HIKARI randomized, placebo-controlled trial.
Mod Rheumatol 2013 published November 1

 
2013  

van der Heijde D, Sieper J, Maksymowych W, Brown M, Lambert R, Rathmann S, Pangal A. Spinal inflammation in the absence of sacroiliac joint inflammation on MRI in patients with active non-radiographic axial spondyloarthritis.
Arthritis Rheum 2013 published November 18

 
2013  

Keystone E, Breedveld F, van der Heijde D, Landewé R, Florentinus S, Arulmani U, Liu S, Kupper H, Kavanaugh A. Longterm effect of delaying combination therapy with tumor necrosis factor inhibitor in patients with aggressive early rheumatoid arthritis: 10-year efficacy and safety of adalimumab from the randomized controlled PREMIER trial with open-label extension.
J Rheumatol 2013 published November 15

 
2013  

Ramiro S, Stolwijk C, van Tubergen A, van der Heijde D, Dougados M, van den Bosch F, Landewé R.Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study.
Ann Rheum Dis published 16 August 2013, 10.1136/annrheumdis-2013-204055

 
2013  

Keystone E, Landewé, van Vollenhoven R, Combe B, Strand V, Mease P, Shaughnessy L, VanLunen B, van der Heijde D. Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension.
Ann Rheum Dis published 5 August 2013, 10.1136/annrheumdis-2013-203695

 
2013  

Baraliakos X, Heldmann F, Callhoff J, Listing J, Appelboom T, Brandt J, Van den Bosch F, Breban M, Burmester GR, Dougados M, Emery P, Gaston H, Grunke M, van der Horst-Bruinsma IE, Landewé R,  Leirisalo-Repo M, Sieper J, De Vlam K, Pappas D, Kiltz U, van der Heijde D, Braun J. Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography.
Ann Rheum Dis published 14 July 2013, 10.1136/annrheumdis-2013-203425

 
2013  

Braun J, Baraliakos X, Hermann K-GA, Deodhar A, van der Heijde D, Inman R, Beutler A, Zhou Y, Xu S, Hsu B. The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial.
Ann Rheum Dis published 3 May 2013, 10.1136/annrheumdis-2012-203075

 
2013  

Navarro-Compan V, van der Heijde D, Ahmad HA, Miller CG, Wolterbeek R, Landewé R. Measurement error in the assessment of radiographic progression in rheumatoid arthritis (RA) clinical trials: the smallest detectable change (SDC) revisited.
Ann Rheum Dis published 20 April 2013, 10.1136/annrheumdis-2012-202939

 
2013  

van Tuyl LHD, van der Heijde D, Knol DL, Boers M. Chronological reading of radiographs in rheumatoid arthritis increases efficiency and does not lead to bias.
Ann Rheum Dis published 24 January 2013, 10.1136/annrheumdis-2012-202876

 
2013  

Hemke R, Doria AS, Tzaribachev N, Maas M, van der Heijde DM, van Rossum MA. Selecting Magnetic Resonance Imaging (MRI) Outcome Measures for Juvenile Idiopathic Arthritis (JIA) Clinical Trials: First Report of the MRI in JIA Special Interest Group.
J Rheumatol 2013 Nov 1;

 
2013  

Ciurea A, Scherer A, Exer P, Bernhard J, Dudler J, Beyeler B, Kissling R, Stekhoven D, Rufibach K, Tamborrini G, Weiss B, Mueller R, Nissen M, Michel B, van der Heijde D, Dougados M, Boonen A, Weber U; Rheumatologists of the Swiss Clinical Quality Management Program for Axial Spondyloarthritis. Tumor necrosis factor-alpha inhibition in radiographic and non-radiographic axial spondyloarthritis: results from a large observational cohort.
Arthritis Rheum 2013 Aug 27, doi: 10.1002/art38140

 
2013  

Grandaunet B, Watterdal Syversen S, Hoff M, Haugeberg G, van der Heijde D, Kvien TK, Standal T. Dickkopf-1 Is Associated with Periarticular Bone Loss in Patients with Rheumatoid Arthritis.
OJRA 2013;3:216-20

 
2013  

Kavanaugh A, McInnes IB, Mease PJ, Krueger GG, Gladman DD, van der Heijde D, Mudivarthy S, Xu W, Mack M, Xu Z, Beutler A. Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study.
Ann Rheum Dis 2013;72:1777-85

 
2013  

Siebuhr A, Bay-Jensen A, Leeming DJ, Platt A, Byrjalsen I, Christiansen C, van der Heijde D, Karsdal M. Serological identification of fast progressors of structural damage with rheumatoid arthritis.
Arthritis Research & Therapy 2013, 15:R86

 
2013  

Krabben A, Stomp W, van der Heijde DMFM, van Nies JAB, Bloem JL, Huizinga TWJ, Reijnierse M, van der Helm-van Mil AHM. MRI of hand and foot joints of patients with anticitrullinated peptide antibody positive arthralgia without clinical arthritis.
Ann Rheum Dis 2013;72:1540-4

 
2013  

Navarro-Compán V, Landewé R, Ahmad HA, Miller CG, Xu D, Wolterbeek R, van der Heijde D.  Rate of adjudication of radiological progression in rheumatoid arthritis randomized controlled trials depending on preset limits of agreement: a pooled analysis from 15 randomized trials.
Rheumatology 2013;52:1404-7

 
2013  

de Hooge M, van den Berg R, Navarro-Compán V, van Gaalen F, van der Heijde D, Huizinga T, Reijnierse M. Magnetic resonance imaging of the sacroiliac joints in the early detection of spondyloarthritis: No added value of gadolinium compared with short tau inversion recovery sequence.
Rheumatology 2013;52:1220-4

 
2013  

Landewé R, Strand V, van der Heijde D. From inhibition of radiographic progression to maintaining structural integrity: a methodological framework for radiographic progression in rheumatoid arthritis and psoriatic arthritis clinical trials.
Ann Rheum Dis 2013;72:1113-7

 
2013  

Mandl P, Balint PV, Brault Y, Backhaus M,  D'Agostino MA, Grassi W, van der Heijde D, de Miguel E, Wakefield RJ, Logeart I, Dougados M. Clinical and Ultrasound-Based Composite Disease Activity Indices in Rheumatoid Arthritis: Results From a Multicenter, Randomized Study.
Arthritis Care Res 2013;65:879–87

 
2013  

Smolen JS, van der Heijde DM, Keystone EC, van Vollenhoven RF, Goldring MB, Guerette B, Cifaldi MA, Chen N, Liu S, Landewé RBM. Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexate.
Ann Rheum Dis 2013;72:1156-62

 
2013  

Koevoets R, Dirven L, Klarenbeek NB, van Krugten MV, Ronday HK, van der Heijde DMFM, Huizinga TWJ, Kerstens PSJM, Lems WF, Allaart CF. Insights in the relationship of joint space narrowing versus erosive joint damage and physical functioning of patients with RA.
Ann Rheum Dis 2013;72:870-4

 
2013  

Sieper J, van der Heijde D, Dougados M, Mease PJ, Maksymowych WP, Brown MA, Arora V, Pangan AL. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).
Ann Rheum Dis 2013;72:815-22

 
2013  

Colebatch AN, Edwards CJ, Østergaard M, van der Heijde D, Balint PV, D'Agostino M-A, Forslind K, Grassi W, Haavardsholm EA, Haugeberg G, Jurik A-G, Landewé RBM, Naredo E, O'Connor PJ, Ostendorf B, Potocki K, Schmidt WA, Smolen JS, Sokolovic S, Watt I, Conaghan PG. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis.
Ann Rheum Dis 2013;72:804-14

 
2013  

Vossen MHE, den Broeder AA, Hendriks-Roelofs F, van der Heijde DMFM, Reijnierse M. Improvement in deployment of MRI of the sacroiliac joints in patients suspected for spondyloarthritis using a targeted intervention: A case study.
Rheumatology 2013;52:933-8

 
2013  

Maehlen, M.T., Provan, S.A., de Rooy, D.P.C., van der Helm-van Mil, A.H.M., Krabben, A., Saxne, T., Lindqvist, E., Semb, A.G., Uhlig, T., van der Heijde, D., Mero, I.L., Olsen, I.C., Kvien, T.K., Lie, B.A. Associations between APOE Genotypes and Disease Susceptibility, Joint Damage and Lipid Levels in Patients with Rheumatoid Arthritis.
PLoS ONE , 2013;8:art. no. e60970

 
2013  

Engvall I-L, Svensson B, Boonen A, van der Heijde D, Lerner UH, Hafström I. Low-dose prednisolone in early rheumatoid arthritis inhibits collagen type I degradation by matrix metalloproteinases as assessed by serum 1CTP-A possible mechanism for specific inhibition of radiological destruction.
Rheumatology 2013;52:733-42

 
2013  

Dougados M, Devauchelle-Pensec V, Ferlet JF, Jousse-Joulin S, D'Agostino M-A, Backhaus M, Bentin J, Chales G, Chary-Valckenaere I, Conaghan P, Wakefield RJ, Etcheparre F, Gaudin P, Grassi W, van der Heijde D, Mariette X, Naredo E, Szkudlarek M. The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasound
Ann Rheum Dis 2013;72;665-71

 
2013  

van der Heijde D, Tanaka Y, Fleischmann R, Keystone E, Kremer J, Zerbini C, Cardiel MH, Cohen S, Nash P, Song Y-W, Tegzová D, Wyman BT, Gruben D, Benda B, Wallenstein G, Krishnaswami S, Zwillich SH,  Bradley JD, Connell CA, and the ORAL Scan Investigators. Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-four–month phase III randomized radiographic study.
Arthritis Rheum 2013;65:559-70

 
2013  

Ramiro S, van Tubergen A, Stolwijk C, Landewe R, van den Bosch F, Dougados M, van der Heijde D. Scoring radiographic progression in ankylosing spondylitis: Should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
Arthritis Research & Therapy 2013, 15:R14 (17 January 2013)

 
2013  

Weinblatt ME, Schiff M, Valente R, van der Heijde D, Citera G, Zhao C, Maldonado M, Fleischmann R.
Head-to-Head Comparison of Subcutaneous Abatacept versus Adalimumab for Rheumatoid Arthritis.
Arthritis Rheum 2013;65:28-38

 
     
2012  

Machado P, Landewé RBM, Braun J, Baraliakos X, Hermann K-GA, Hsu B, Baker D, van der Heijde D. MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor.
Ann Rheum Dis 2012;71:2002-5

 
2012  

van Tubergen A, van der Heijde D, Dougados M, Mielants H, Landewé R. Are syndesmophytes most prevalent in the lumbar or in the cervical spine in patients with ankylosing spondylitis and do they develop in a specific direction?
Rheumatology 2012;51:1432-9

 
2012  

Keystone EC, Combe B, Smolen J, Strand V, Goel N, van Vollenhoven R, Mease P, Landewé R, Fleischmann R, Luijtens K, van der Heijde D. Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trial.
Rheumatology 2012;51:1628-38

 
2012  

Kroon F, Landewé R, Dougados M, van der Heijde D. Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis.
Ann Rheum Dis 2012;71:1623-9

 
2012  

Moreland LW, O'Dell JR, Paulus HE, Curtis JR, Bathon JM, St.Clair EW, Bridges Jr SL, Zhang J, McVie T, Howard G, van der Heijde D, Cofield SS.  A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The treatment of early aggressive rheumatoid arthritis trial.
Arthritis Rheum 2012;64:2824–35

 
2012  

Kavanaugh A, van der Heijde D, McInnes IB, Mease P, Krueger GG, Gladman DD, Gómez-Reino J, Papp K, Baratelle A, Xu W, Mudivarthy S, Mack M, Rahman MU, Xu Z, Zrubek J, Beutler A. Golimumab in psoriatic arthritis: One-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial.
Arthritis Rheum 2012;64:2504–17

 
2012  

Hermann K-G, Baraliakos X, van der Heijde DMFM, Jurik A-G, Landewé R, Marzo-Ortega H, Østergaard M, Rudwaleit M, Sieper J, Braun J. Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: A consensual approach by the ASAS/OMERACT MRI study group.
Ann Rheum Dis 2012;71:1278-88

 
2012  

Chung H-Y, Machado P, van der Heijde D, D'Agostino M-A, Dougados M. Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort.
Ann Rheum Dis published 2012;71:809-16

 
2012  

Haugen IK, Bøyesen P,  Slatkowsky-Christensen B, Sesseng S, van der Heijde D, Kvien TK.  Associations between MRI-defined synovitis, bone marrow lesions and structural features and measures of pain and physical function in hand osteoarthritis.
Ann Rheum Dis 2012;71:899-904

 
2012  

Braun J, Baraliakos X, Hermann K-G, van der Heijde D, Inman RD, Deodhar AA, Baratelle A, Xu S, Xu W, Hsu B. Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study.
Ann Rheum Dis 2012;71:878-84

 
2012  

van der Heijde D. Remission by imaging in rheumatoid arthritis: should this be the ultimate goal?
Ann Rheum Dis 2012;71 i89-i92

 
2012  

Mandl P, Balint PV, Brault Y, Backhaus M, D'Agostino M-A, Grassi W, van der Heijde D, de Miguel D, Wakefield RJ, Logeart I, Dougados M. Metrologic properties of ultrasound versus clinical evaluation of synovitis in rheumatoid arthritis: Results of a multicenter, randomized study.
Arthritis Rheum 2012;64:1272-82

 
2012  

van Tubergen A, Ramiro S, van der Heijde D, Dougados M, Mielants H, Landewé R. Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study.
Ann Rheum Dis 2012;71 518-23

 
2012  

Lillegraven S, van der Heijde D, Uhlig T, Kvien TK, Haavardsholm E. What is the clinical relevance of erosions and joint space narrowing in RA?
Nat Rev Rheumatol 2012;8:117-20

 
2012  

van der Heijde D, Machado P, Braun J, Hermann K-GA, Baraliakos X, Hsu B, Baker D, Landewé R. MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis.
Ann Rheum Dis 2012;71:369-73

 
2012  

Haugen IK, Bøyesen P, Slatkowsky-Christensen B, Sesseng S, Bijsterbosch J, van der Heijde D, Kvien TK. Comparison of features by MRI and radiographs of the interphalangeal finger joints in patients with hand osteoarthritis.
Ann Rheum Dis 2012;71:345-50

 
     
2011  

Landewé R, van der Heijde D. New considerations in the design of clinical trials for ankylosing spondylitis.
Clinical Investigation 2011;1:1505-12

 
2011  

Baraliakos X, Landewé R, van der Heijde D, Listing J, Baker D, Hsu B, Braun J. The relationship of biomarkers and radiographic progression in patients treated with infliximab.
Eur Musc Rev 2011;6:94-95

 
2011  

Emery P, van der Heijde D, Østergaard M, Conaghan PG, Genovese MC, Keystone EC, Fleischmann R, Hsia EC, Xu W, Xu S, Rahman MU. Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis.
Ann Rheum Dis 2011;70:2126-30

 
2011  

van Onna M,  Jurik AG, van der Heijde D, van Tubergen A, Heuft-Dorenbosch L, Landewé R. HLA-B27 and gender independently determine the likelihood of a positive MRI of the sacroiliac joints in patients with early inflammatory back pain: a 2-year MRI follow-up study.
Ann Rheum Dis 2011;70:1981-5

 
2011  

Chung HY, Machado P, van der Heijde D, D'Agostino M-A, Dougados M. HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis.
Ann Rheum Dis 2011;70:1930-6

 
2011  

Klarenbeek NB, Koevoets R, van der Heijde DMFM, Gerards AH, tenWolde S, Kerstens PJSM, Huizinga TWJ, Dijkmans BAC, Allaart CF. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.
Ann Rheum Dis 2011;70:1815-21

 
2011  

Strand V, Kingsbury SR, Woodworth T, Landewé R, Ostergaard M, Peterfy C, van der Heijde D, D’Agostino MA, Maksymowych W, Tak PP, Wells G, Conaghan PG. OMERACT 10 Sharp symposium: Important findings in examination of imaging methods for measurement of joint damage in rheumatoid arthritis.
J Rheumatol 2011;38:2009-13

 
2011  

Landewé RB, Strand V, Conaghan PG, van der Heijde D. Damage and progression on radiographs in individual joints: data from pivotal randomized controlled trials.
J Rheumatol 2011;38:2018-22

 
2011  

Baraliakos X, van der Heijde D, Braun J, Landewé RB. OMERACT Magnetic Resonance Imaging initiative on structural and inflammatory lesions in ankylosing spondylitis – Report of a Special Interest Group at OMERACT 10 on sacroiliac joint and spine lesions.
J Rheumatol 2011;38:2051-4

 
2011  

Giles JT, van der Heijde DM, Bathon JM. Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis.
Ann Rheum Dis 2011;70 1562-1568

 
2011  

Lukas C, Combe B, Ravaud P, Sibilia J, Landewé R, D van der Heijde. Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis data from the Etude et Suivi des Polyarthrites Indiffe ́rencie ́es Re ́centes (Study and Followup of Early Undifferentiated Polyarthritis).
Arthritis Rheum 2011;63:1804-11

 
2011  

Bijsterbosch J, Haugen IK, Malines C, Maheu E, Rosendaal FR, Watt I, Berenbaum F, Kvien TK, van der Heijde DM, Huizinga TWJ, Kloppenburg M. Reliability, sensitivity to change and feasibility of three radiographic scoring methods for hand osteoarthritis.
Ann Rheum Dis 2011;70 1465-7

 
2011  

van der Heijde D, Landewé R. Dramatic repair of joint damage in psoriatic arthritis.
J Rheumatol 2011;38:969-70

 
2011  

Emery P, Fleischmann R, van der Heijde D, Keystone EC, Genovese MC, Conaghan PG, Hsia EC, Xu W, Baratelle A, Beutler A, Rahman MU.  The effects of golimumab on radiographic progression in rheumatoid arthritis: Results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy.
Arthritis Rheum 2011;63:1200-10

 
2011  

Bøyesen P, Haavardsholm EA, Østergaard M, van der Heijde D, Sesseng S, Kvien TK. MRI in early rheumatoid arthritis: synovitis and bone marrow oedema are independent predictors of subsequent radiographic progression.
Ann Rheum Dis 2011;70 428-433

 
2011  

Bøyesen P, Haavardsholm EA, van der Heijde D, Østergaard M, Berner Hammer H, Sesseng S, Kvien TK. Prediction of MRI erosive progression: a comparison of modern imaging modalities in early rheumatoid arthritis patients.
Ann Rheum Dis 2011;70:176-9

 
2011   Grandaunet B, Syversen SW, Hoff M, Sundan A, Haugeberg G, van der Heijde D, Kvien TK, Standal T. Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritis. Arthritis Rheum 2011;63:662-9  
2011  

van der Heijde D. Erosions versus joint space narrowing in rheumatoid arthritis: what do we know?
Ann Rheum Dis 2011;70 i116-i118

 
2011  

Hashimoto J, Garnero P, van der Heijde D, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Yoshikawa H, Nishimoto N.Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study.
Mod Rheumatol. 2011;21:10-5

 
2011  

Koevoets R, Machado P, Bombardier C, van der Heijde DM. The value of conventional radiographs in undifferentiated arthritis: a systematic review.
J Rheumatol 2011;38:Suppl 87:26-30

 
2011  

Machado PMMS, Koevoets R, Bombardier C, van der Heijde DM. The value of magnetic resonance imaging and ultrasound in undifferentiated arthritis: a systematic review.
J Rheumatol 2011;38:Suppl 87:31-7

 
2011  

Landewé R, van der Heijde D. Joint space narrowing, cartilage and physical function: are we deceived by measurements and distributions?
Ann Rheum Dis 2011;70 717-18

 
2011  

Haugen IK, Lillegraven S, Slatkowsky-Christensen B, Haavardsholm EA, Sesseng S, Kvien TK, van der Heijde D, Boyesen P. Hand osteoarthritis and MRI: development and first validation step of the proposed Oslo Hand Osteoarthritis MRI score.
Ann Rheum Dis 2011;70:1033-8

 
     
2010  

Syversen SW, Goll GL, van der Heijde D, Landewé R, Lie BA, Ødegard S, Uhlig T, Gaarder PI, Kvien TK. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study.
Ann Rheum Dis 2010;69 345-351

 
2010  

Emery P, Breedveld F, van der Heijde D, Ferraccioli G, Dougados M, Robertson D, Pedersen R, Koenig AS, Freundlich B, for the Combination of Methotrexate and Etanercept in Early Rheumatoid Arthritis Trial Group. Two-year clinical and radiographic results with combination etanercept-methotrexate therapy versus monotherapy in early rheumatoid arthritis.
Arthritis Rheum 2010;62:674-82

 
2010  

van der Linden MPM, Boja R, Klarenbeek NB, Huizinga TWJ, van der Heijde DM, van der Helm-van Mil AHM. Repair of joint erosions in rheumatoid arthritis: prevalence and patient characteristics in a large inception cohort.
Ann Rheum Dis 2010;69:727-9

 
2010  

Bridges Jr SL, Causey ZL, Burgos PI, Huynh BQN, Hughes LB, Danila M, van Everdingen A, Ledbetter S, Conn DL, Tamhane A, Westfall AO, Jonas BL, Callahan LF, Smith EA, Brasington R, Moreland LW, Alarcón GS, van der Heijde DM. Radiographic severity of Rheumatoid Arthritis in African Americans: Results from a multicenter observational study.
Arthritis Care & Research 2010;62:624-31

 
2010  

Lukas C, van der Heijde D, Fatenejad S, Landewé R. Repair of erosions occurs almost exclusively in damaged joints without swelling.
Ann Rheum Dis 2010;69:851-5

 
2010  

Syversen SW, Haavardsholm EA, Boyesen P, Goll GL, Okkenhaug C, Gaarder PI, van der Heijde D, Kvien TK. Biomarkers in early rheumatoid arthritis: longitudinal associations with inflammation and joint destruction measured by magnetic resonance imaging and conventional radiographs.
Ann Rheum Dis 2010;69:845-50

 
2010  

van der Woude D, Syversen SW, van der Voort EIH, Verpoort KN, Goll GL, van der Linden MPM, van der Helm-van Mil AHM, van der Heijde DMFM, Huizinga TWJ, Kvien TK, REM Toes. The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis.
Ann Rheum Dis 2010;69:1110-6

 
2010  

Machado P, Landewé R, Braun J, Hermann KG, Baker D, van der Heijde D. Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis.
Ann Rheum Dis 2010;69:1465-70

 
2010  

van der Heijde D, Breedveld FC, Kavanaugh A, Keystone EC, Landewé R, Patra K, Pangan AL. Disease Activity, Physical Function, and Radiographic Progression After Longterm Therapy with Adalimumab Plus Methotrexate: 5-Year Results of PREMIER.
J Rheumatol 2010; Oct 1 Epub

 
2010  

Zhang J, Redden DT, McGwin G Jr, Callahan LF, Smith EA, Alarcón GS, Moreland LW, van der Heijde DM, Brown EE, Arnett DK, Mikuls TR, Bridges SL Jr, for the Consortium for the Longitudinal Evaluations of African Americans with Early Rheumatoid Arthritis Investigators. Generalized bone loss as a predictor of three-year radiographic damage in African American patients with recent-onset rheumatoid arthritis.
Arthritis Rheum 2010;62:2219-26

 
2010  

van der Helm-van Mil AHM, Knevel R, van der Heijde D, Huizinga TWJ. How to avoid phenotypic misclassification in using joint destruction as an outcome measure for rheumatoid arthritis?
Rheumatology 2010;49:1429-35

 
2010  

Dougados M, Jousse-Joulin S, Mistretta F, D'Agostino M-A, Backhaus M, Bentin J, Chales G, Chary-Valckenaere I, Conaghan P, Etchepare F, Gaudin P, Grassi W, van der Heijde D, Sellam J, Naredo E, Szkudlarek M, Wakefield R, Saraux A. Evaluation of several ultrasonography scoring systems of synovitis and comparison to clinical examination: Results from a prospective multi-center study of rheumatoid arthritis.
Ann Rheum Dis 2010;69:828-35

 
2010  

van der Heijde D, Rudwaleit M, Landewe RBM, Sieper J. Justification for including MRI as a tool in the diagnosis of axial SpA.
Nat Rev Rheumatol 2010:6:670–2 (doi:10.1038/nrrheum.2010.160)

 
2010  

Klarenbeek NB, Guler-Yuksel M, van der Heijde DMFM, Hulsmans HMJ, Kerstens PJSM, Molenaar THE, de Sonnaville PBJ, Huizinga TWJ, Dijkmans BAC, Allaart CF. Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximab.
Ann Rheum Dis published 2010;69 2107-13

 
     
2009  

Vosse D, Landewé R, van der Heijde D, van der Linden S, van Staa T-P, Geusens P. Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case control study.
Ann Rheum Dis 2009;68:1839-42

 
2009  

Landewé R, van der Heijde D. A systematic comparison of rheumatoid arthritis and ankylosing spondylitis: Structural outcomes.
Clin Exp Rheumatol 2009;27 (4 suppl 55):S102-S107

 
2009  

Syversen SW, Landewé R, van der Heijde D, Bathon JM, Boers M, Bykerk VP, Fitzgerald O, Gladman DD, Garnero P, Geusens P, Gladman DD, El-Gabalawy H, Inman RD, Kraus V, Kvien TK, Mease PJ, Østergaard M, Ritchlin CJ, Tak P-P, Taylor WJ, Maksymowych WP. Testing of the OMERACT 8 Draft Validation Criteria for a Soluble Biomarker Reflecting Structural Damage in RA: A Systematic Literature Search on 5 Candidate Biomarkers.
J Rheumatol 2009;36:1769-84

 
2009  

Maksymowych WP, Landewé R, Tak P-P, Ritchlin CJ, Østergaard M, Mease PJ, El-Gabalawy H, Garnero P, Gladman DD, Fitzgerald O, Aletaha D, Bykerk VP, Bathon JM, Syversen SW, Boers M, Geusens P, Inman RD, Kraus V, Kvien TK, Taylor WJ, Wells GA, van der Heijde D. Reappraisal of OMERACT 8 Draft Validation Criteria for a Soluble Biomarker Reflecting Structural Damage Endpoints in RA, PsA, and Spondyloarthritis: The OMERACT 9 v2 Criteria
J Rheumatol 2009;36:1785-91

 
2009  

Maksymowych WP, Fitzgerald O, Wells GA, Gladman DD, Landewé R, Østergaard M, Taylor WJ, Christensen R, Tak P-P, Boers M, Syversen SW, Bathon JM, Ritchlin CJ, Mease PJ, Bykerk VP, Garnero P, Geusens P, El-Gabalawy H, Aletaha D, Inman RD, Byers Kraus V, Kvien TK, van der Heijde D. Proposal for Levels of Evidence Schema for Validation of a Soluble Biomarker Reflecting Damage Endpoints in RA, PsA, and AS, and Recommendations for Study Design
J Rheumatol 2009;36:1792-9

 
2009  

Thabet M, Huizing TWJ, van der Heijde DM, van der Helm-van Mil AHM. The prognostic value of baseline erosions in undifferentiated arthritis.
Arthr Res Ther 2009;11:R155

 
2009  

van der Heijde D, Burmester GR, Melo-Gomes JR, Codreanu C, Martin Mola E, Pedersen R, Robertson D, Chang D, Koenig AS, Freundlich B. Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy
Ann Rheum Dis
2009:68:1113-8

 
2009  

Berner Hammer H, Ødegard S, Syversen SW, Landewé R, van der Heijde D, Uhlig T, Møwinckel, Kvien TK. Calprotectin (a major S100 leukocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis.
Ann Rheum Dis 2010;69:150-4

 
2009  

Lukas C, Landewé RBM, Fatenejad S, van der Heijde DMFM. Subtle changes in individual joints result in both positive and negative change scores in a patient: Results from a clinical trial in patients with rheumatoid arthritis.
Ann Rheum Dis 2009;68:1691-5

 
2009  

Haavardsholm A, Østergaard M, Berner Hammer H, Boyesen P, Boonen A, van der Heijde D, Kvien TK.
Monitoring anti-TNF{alpha} treatment in RA: Responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist compared to conventional measures of disease activity and structural damage.
Ann Rheum Dis 2009:68:1572-9

 
2009  

Smolen JS, van der Heijde DMFM, Aletaha D, Xu S, Han J, Baker D, St.Clair EW. Progression of radiographic joint damage in rheumatoid arthritis: Independence of erosions and joint space narrowing.
Ann Rheum Dis 2009;68:1535-40

 
2009  

Hashimoto J. Garnero P, van der Heijde D, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Yoshikawa H, Nishimoto N. A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs.
Mod Rheumatol 2009;19:273-82

 
2009  

Smolen JS, Landewé RBM, Mease PJ, Brzezicki J, Mason D, Luijtens K, van Vollenhoven RF,  Kavanaugh A, Schiff MH, Burmester GR, Strand V, Vencovsky J, van der Heijde DMFM. Efficacy and Safety of Certolizumab Pegol Plus Methotrexate in Active Rheumatoid Arthritis: The RAPID 2 Study. A randomized controlled. Trial.
Ann Rheum Dis 2009;68 797-804

 
2009  

Halvorsen EH, Haavardsholm EA, Pollmann S, Boonen A, van der Heijde D, Kvien TK, Molberg Ø. Serum IgG antibodies to Peptidylarginine Deiminase 4 predict radiographic progression in rheumatoid arthritis patients treated with TNF-{alpha} blocking agents.
Ann Rheum Dis  2009;68:249-52

 
2009  

Landewé R, Dougados M, Mielants H, van der Tempel H, van der Heijde D. Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine.
Ann Rheum Dis 2009;68 863-867

 
2009  

Smolen J, Han C, van der Heijde D, Emery P, Bathon J, Keystone E, Maini R, Kalden J, Aletaha D, Baker D, Han J, Bala M, St.Clair E. Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and TNF-blockade.
Ann Rheum Dis 2009;68 823-827

 
2009  

Hafstrom I, Albertsson K, Boonen A, van der Heijde D, Landewé R.B.M, Svensson B, Remission achieved  after 2 years treatment with low dose prednisolone in addition to DMARD’s in early RA is associated with reduced joint destruction still present after 4 years: an open two year continuation study.
Ann Rheum Dis 2009;68:508-513

 
2009  

Hoff M, Haugeberg G, Ødegard S, Syversen SW, Landewé R, van der Heijde D, Kvien K. Cortical hand bone loss after one year in early rheumatoid arthritis predicts radiographic hand joint damage at 5 and 10 year follow-up.
Ann Rheum Dis 2009;68:324-9

 
2009  

Syversen SW, Goll GL, van der Heijde D, Landewé R, Gaarder PI, Odegard S, Haavardsholm EA, Kvien TK. Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression.
J Rheumatol 2009;36:2-7

 
2009  

Berner Hammer H, Ødegard S, Syversen SW, Landewé R, van der Heijde D, Uhlig T, Møwinckel, Kvien TK. Calprotectin (a major S100 leukocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis.
Ann Rheum Dis published 18 December 2008, 10.1136/ard.2008.103739 

 
2009  

Lukas C, Landewé RBM, Fatenejad S, van der Heijde DMFM. Subtle changes in individual joints result in both positive and negative change scores in a patient: Results from a clinical trial in patients with rheumatoid arthritis.
Ann Rheum Dis published 24 November 2008, 10.1136/ard.2008.097816

 
2009  

Haavardsholm A, Østergaard M, Berner Hammer H, Boyesen P, Boonen A, van der Heijde D, Kvien TK.
Monitoring anti-TNF{alpha} treatment in RA: Responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist compared to conventional measures of disease activity and structural damage.
Ann Rheum Dis published 19 November 2008, 10.1136/ard.2008.091801

 
2009  

Smolen JS, van der Heijde DMFM, Aletaha D, Xu S, Han J, Baker D, St.Clair EW. Progression of radiographic joint damage in rheumatoid arthritis: Independence of erosions and joint space narrowing.|
Ann Rheum Dis published 28 October 2008, 10.1136/ard.2008.094128

 
     
2008  

Keystone E, van der Heijde D, Mason D Jr, Landewé R, van Vollenhoven R, Combe B, Emery P, Strand V, Mease P, Desai C, Pavelka K. Certolizumab Pegol Plus Methotrexate Is Significantly More Effective Than Placebo Plus Methotrexate in Active Rheumatoid Arthritis. Findings of a Fifty-Two-Week, Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.
Arthritis Rheum. 2008:58:3319-29

 
2008  

van der Heijde D, Landewé R, Baraliakos X, Houben H, van Tubergen A, Williamson P, Xu W, Baker D, Goldstein N, Braun J, the Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.
Arthritis Rheum 2008;58: 3063-70

 
2008  

Vosse D, Landewé R, Garnero P, van der Heijde D, van der Linden S, Geusens P. Association of markers of bone- and cartilagedegradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitis.
Rheumatology 2008;47(8):1219-22

 
2008  

Lukas C, Sharp JT, Angwin J, Boers M, Duryea J, Hall JR, Kauffman JA, Landewé R, Langs G, Bernelot Moens HJ, Peloschek P, van der Heijde D. Automated measurement of joint space width in small joints of patients with rheumatoid arthritis.
J Rheumatol. 2008;35(7):1288-1293

 
2008  

Antoni CE, Kavanaugh A, van der Heijde D, Beutler A, Keenan G, Zhou B, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, Furst DE, Molitor J, Keystone E, Gladman DD, Manger B, Wassenberg S, Weier R, Wallace DJ, Weisman MH, Kalden JR, Smolen JS. Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: Findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).
J Rheum 2008;35(5):869-76

 
2008  

Cohen S, Dore R, Lane N, Ory P, Peterfy C, Sharp J, van der Heijde D, Zhou L, Tsuji W, Newmark R. Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial.
Arthritis Rheum 2008;58(5):1299-309

 
2008  

van der Heijde D, Landewé R, Einstein S, Ory P, Vosse D, Ni L, Lin S.-L, Tsuji W, Davis Jr. J. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept.
Arthritis Rheum 2008;58(5):1324-31

 
2008  

Halvorsen EH, Pollmann S, Gilboe IM, van der Heijde D, Landewé R, Ødegard S, Kvien TK, Molberg, O. Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity.
Ann Rheum Dis 2008;67(3):414-7

 
2008  

Dias EM, Lukas C, Landewé R, Fatenejad S, van der Heijde D. Reliability and sensitivity to change of the Simple Erosion Narrowing Score compared with the Sharp-van der Heijde method for scoring radiographs in rheumatoid arthritis.
Ann Rheum Dis 2008;67:375-9

 
2008  

Mikuls TR, Hughes LB, Westfall AO, Holers VM, Parrish L, van der Heijde D, van Everdingen M, Alarcon GS, Conn DL, Jonas B, Callahan LF, Smith EA, Gilkeson G, Howerd G, Moreland LW, Bridges Jr SL. Cigarette smoking, disease severity, and autoantibody expression in African American with recent-onset rheumatoid arthritis.
Ann Rheum Dis 2008;67 1529-1534

 
2008  

van der Heijde D, Landewé R, van Vollenhoven R, Fatenejad S, Klareskog L. Level of radiographic damage and radiographic progression are determinants of phycical function: a longitudinal analysis of the TEMPO trial.
Ann Rheum Dis 2008;67:1267-70

 
2008  

Syversen SW, Gaarder PI, Goll GL, Odegard S, Haavardsholm EA, Mowinckel P, van der Heijde D, Landewé R, Kvien TK. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.
Ann Rheum Dis 2008;67:212-7

 
2008  

van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Martin Mola E, Pedersen R, Freundlich B, Chang DJ. For the Etanercept Study 400 investigators. The safety and efficacy of addiing etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
Ann Rheum Dis 2008;67:182-8

 
2008  

Dias EM, Lukas C, Landewé R, Fatenejad S, van der Heijde D. Reliability and sensitivity to change of the Simple Erosion Narrowing Score compared with the Sharp-van der Heijde method for scoring radiographs in rheumatoid arthritis.
Ann Rheum Dis 2008; 67(3):375-379

 
     
2007  

Lukas C, Braun J, van der Heijde D, Hermann KG, Rudwaleit M, Ostergaard M, Oostveen A, O’Connor P, Maksymowych WP, Lambert RG, Jurik AG, Baraliakos X, Landewé R; ASAS/OMERACT MRI in AS Working Group. Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment.
J Rheumatol 2007;34(4):862-70

 
2007  

van der Heijde D, Landewé R, Hermann KG, Rudwaleit M, Ostergaard M, Oostveen A, O’Connor P, Maksymowych WP, Lambert RG, Lukas C, Jurik AG, Boers M, Baraliakos X, Braun J; ASAS/OMERACT MRI in AS Working Group. Is there a preferred method for scoring activity of the spine by magnetic resonance imaging in ankylosing spondylitis?
J Rheumatol. 2007 Apr;34(4):871-3

 
2007  

Sharp JT, Angwin J, Boers M, Duryea J, von Ingersleben G, Hall JR, Kauffman JA, Landewé R, Langs G. Lukas C, Maillefert JF, Bernelot Moens HJ, Peloschek P, Strand V, van der Heijde D. Computer based methods for measurement of joint space width: update of an ongoing OMERACT project.
J Rheumatol. 2007 Apr; 34(4):874-83

 
2007  

Lie BA, Viken MK, Odegard S, van der Heijde D, Landewé R, Uhlig T, Kvien TK. Associations between the PTPN22 1858C>T polymorphism and radiographic joint destruction in patients with rheumatoid arthritis: Results from a 10-year longitudinal study.
Ann Rehum Dis;66:1604-09

 
2007  

Nishimoto N, Hashimoto J, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Murata N, van der Heijde D, Kishimoto T. Study of Active Controlled Monotherapy Used for Rheumatoid Arthritis, an IL-6 inhibitor (SAMURAI): - Evidence of clinical and radiographic benefit from an X-Ray Reader-Blinded Randomized Controlled Trial of Tocilizumab.
Ann Rehum Dis. 2007;66:1162-7

 
2007  

van der Heijde D, Landewé R, Boonen A, Einstein SG, Herborn G, Rau R, Wassenberg S, Weissman BV, Winalski CS, Sharp JT. Expert agreement confirms that negative changes in hand and foot radiographs are a surrogate for repair in patients with rheumatoid arthritis.
Arthritis Res Ther. 2007 Jul 2;9(4):R62

 
2007  

van der Heijde D, Kavanaugh A, Gladman DD, Antoni C, Krueger GG, Guzzo C, Zhou B, Dooley LT, de Vlam K, Geusens P, Birbara C, Halter D, Beutler A; IMPACT 2 Study Group Members of the IMPACT 2 Study Group are shown in Appendix A. Inflixmab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2.
Arthritis Rheum. 2007 Jul 30;56980:2698-2707

 
2007  

Van der Heijde D, Klareskog L, Landewé R, Bruyn GA, Cantagrel A, Durez P, Herrero-Beaumont G, Molad Y, Codreanu C, Valentini G, Zahora R, Pedersen R, MacPeek D, Wajdula S, Fatenejad S.; TEMPO Study Investigators. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.
Arthritis Rheum. 2007;56:3883-6

 
     
2006  

Heuft-Dorenbosch L, Weijers R, Landewé  R,  van der Linden Sj, van der Heijde D. Magnetic Resonance Imaging changes of sacroiliac joints in patients with recent-onset inflammatory back pain: inter-reader reliability and prevalence of abnormalities.
Arthritis Res Therapy 2006;8:R11

 
2006  

Ødegård S, Landewé R, van der Heijde D, Kvien T, Mowinckel P, Uhlig T. Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients.
Arthritis Rheum. 2006 Jan;54(1):68-75

 
2006  

Kavanaugh A, Antoni C, Gladman D, Wassenberg S, Zhou B, Beutler A, Keenan G, Burmester G,  Furst D, Weisman M, Kalden J, Smolen J, van der Heijde D. The Infliximab Multinational Psoriatic Arthritis  Controlled Trial  (IMPACT):  Results of radiographic  analyses after 1 year. 
Ann Rheum Dis published on 13 February 2006 as 10.1136/ard.2005.04565

 
2006  

Heuft-Dorenbosch L, Landewé R, Weijers R, Wanders A, Houben H, van der Linden S, van der Heijde D.
Combining information obtained from MRI and conventional radiographs in order to detect sacroiliitis in patients with recent-onset inflammatory back pain.

Ann Rheum Dis 2006;65:804-808

 
2006  

Smolen JS, van der Heijde DM, St. Clair EW, Emery P, Bathon JM, Keystone E, Maini RN, Kalden JR, Schiff M, Baker D, Han C, Han J, Bala M for the active-controlled study of patients receiving infliximab for the treatment of rheumatoid arthritis of earlyh onset (ASPIRE) study group.  Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.
Arthritis Rheum. 2006;54(3):702-10

 
2006  

van der Heijde D, Klareskog L, Rodriguez-Valverde V, Codreanu C, Bolosiu H, Melo-Gomes J, Tornero-Molina J, Wajdula J, Pedersen R and Fatenejad S for the TEMPO Study Investigators. Comparison of Etanercept and Methotrexate, Alone and Combined, in the the Treatment of Rheumatoid Arthritis: Two-Year Clinical and Radiography Results from the TEMPO Study, ad Double-Blind, Randomized Trial.
Arthritis Rheum 2006;54(4):1063-1074

 
2006  

Geusens P, Landewé R, Garnero P, Chen D, Dunstan D, Lems W, Stinissen P, van der Heijde D, van der Linden S, Boers. The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction.
Arthritis Rheum 2006;54:1772-1777

 
2006  

Braun J, Landewé R, Hermann K-G,Han J, Yan S, Williamson P,  van der Heijde D for the ASSERT Study Group. Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study.
Arthritis Rheum 2006;54(5):1646-1652

 
2006  

Mease P, van der Heijde D. Joint damage in psoriatic arthritis: how is it assessed and can it be prevented ?
Int J Adv Rheumatol 2006;4(2):38-48

 
2006  

Landewé R, van der Heijde D., Klareskog L, van Vollenhoven R, Fatenejad S. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes.
Arthritis Rheum 2006;54(10):3119-25

 
2006  

Heuft-Dorenbosch L, Weijers R, Landewé R, van der Linden S, van der Heijde D. Magnetic resonance imaging changes of sacroiliac joints in patients with recent-onset inflammatory back pain: inter-reader reliability and prevalence of abnormalities.
Arthritis Res Ther 2006;8(1):R11

 
2006  

van der Heijde D, Klareskog L, Rodriguez-Valverde V, Codreanu C, Bolosiu H, Melo-Gomes J, Tornero-Molina J, Wajdula J, Pedersen R, Fatenejad S; TEMPO Study Investigators. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.
Arthritis Rheum 2006;54(4):1063-74

 
     
2005  

van der Heijde D, Sharp J, Wassenberg S, Gladman D. Psoriatic arthritis imaging: a review of scoring methods.
Ann Rheum Dis 2005;64 suppl 2:ii61-4

 
2005  

van der Heijde D,  Landewé R, Klareskog L, Rodríguez-Valverde V,  Settas L,  Pedersen R,  Fatenejad S.. Presentation and analysis of  data on radiographic outcome in clinical trials: experience from the TEMPO study.
Arthritis Rheum 2005;52:49-60

 
2005  

Wanders A, van der Heijde D, Landewe R, Behier JM, Calin A, Olivieri I, Zeidler H, Dougados M. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial.
Arthritis Rheum 2005;52:1756-1765

 
2005  

Bruynesteyn K, Boers M, Kostense P, van der Linden S, van der Heijde D. Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change
Ann Rheum Dis 2005;64:179-182

 
2005  

Baraliakos X, Landewé R, Hermann K-G, Listing J, Golder W, Brandt J, Rudwaleit M, Bollow M, Sieper J, van der Heijde D, Braun J. Inflammation in ankylosing spondylitis – a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging (MRI)
Ann Rheum Dis 2005;64:730-4

 
2005  

Baraliakos X, Hermann K-G, Landewé R, Listing J, Golder W, Brandt J, Rudwaleit M, Bollow M, Sieper J, van der Heijde D, Braun J. Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging (MRI): a comparison between contrast enhanced T1 and short-tau inversion recovery (STIR) sequences.
Ann Rheum Dis 2005;64:1141-1144

 
2005  

van der Heijde D, Landewe R. Imaging in spondylitis.
Curr Opin Rheumatol 2005;17(4):413-7

 
2005  

Smolen JS, Han C, Bala M, Maini RN, Kalden JR, van der Heijde D, Breedveld FC, Furst DE amd Lipsky PE for the ATTRACT Study Group. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study
Arthritis Rheum 2005;52;1020-1030

 
2005   van der Heijde D, Landewé R, van der Linden S. How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured?
Arthritis Rheum 2005;52:1979-1985
 
2005  

Sharp JT, van der Heijde D, Angwin J, Duryea J, Bernelot Moens HJ, Jacobs JW, Maillfert JF, Strand CV. Measurement of Joint Space Width and Erosion Size
J Rheumatol 2005;32(12):2456-61

 
2005  

Landewé R, van der Heijde D. Presentation and analysis of radiographic data in clinical trials and observational studies.
Ann Rheum Dis 2005;64 suppl IV:i48-51

 
2005  

Svensson B, Boonen A, Albertsson K, van der Heijde D, Keller C, Hafström I for the BARFOT Study Group. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate.
Arthritis Rheum 2005;52:3360-70

 
2005  

Landewé R, van der Heijde D. Radiographic progression in rheumatoid arthritis.
Clin Exp Rheum 2005;23(suppl 39):S63-S68

 
2005  

van der Heijde  D, Landewé R, Hermann K-G,  Jurik A-G, Maksymowych W,  Rudwaleit M, O’Connor P,  Braun J and the ASAS/OMERACT MRI in AS working group. Application of the OMERACT filter to scoring methods for MRI of the SI joints and the spine. Recommendations for a research agenda at OMERACT 7.
J Rheumatol 2005;32:2042-7

 
2005  

van der Heijde D, Landewé R, and the ASAS working group. Selection of a method for scoring radiographs for  AS clinical trials by ASAS and OMERACT.
J. Reumatol 2005;32:2048-58

 
2005  

Landewé  R,  Hermann  K-G, van der Heijde  D,  Baraliakos  X, Jurik A-G, Lambert R, Østergaard M, Rudwaleit M, Salonen D, Braun J and the ASAS/OMERACT MRI in AS working group. Scoring sacro-iliac joints by magnetic resonance imaging, a  multiple-reader reliability experiment.
J Rheumatol  2005;32:2050-5

 
     
2004  

van der Heijde D. Overview of radiologic efficacy of new treatments.
Rheum Dis Clin North Am 2004;30(2):285-93

 
2004  

Bruynesteyn K, Landewé R, van der Linden S, van der Heijde D.Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months’ follow- up.
Ann Rheum Dis 2004;63(11):1413-1418

 
2004  

Landewé R, van der Heijde D. Radiographic progression depicted by probability plots: presenting data with optimal use of individual values.
Arthritis Rheum 2004;50(3):699-706

 
2004  

Spoorenberg A, de Vlam K, van der Linden S, Dougados M, Mielants H, van de Tempel H, van der Heijde D. Radiological scoring methods in ankylosing spondylitis. Reliability and change over 1 and 2 years.
J Rheumatol 2004;31(1):125-32.

 
2004  

van der Heijde D, Assessment of radiographs in longitudinal observational studies.
J Rheum 2004;31 Suppl 69:46-47

 
2004  

van der Heijde D, Kalden JR, Scott D, Smolen J, Strand V. Long-term evaluation of radiographic disease progression in a subset of patients with rheumatoid arthritis treated with leflunomide beyond 2 years: concise report.
Ann Rheum Dis 2004;63(6)737-9 

 
2004  

Bruynesteyn K, van der Linden Sj, Landewé R, Gubler F, Weijers R, van der Heijde D. Progression of RA on plain films judged differently by expert radiologists and rheumatologists.
J Rheumatol 2004;31(6):1088-94

 
2004  

Braun J, Baraliakos X, Golder W, Hermann K-G, Listing J, Brandt J, Rudwaleit M, Zühlsdorf  S, Bollow M, Sieper J, van der Heijde D. Analysing chronic spinal changes in ankylosing spondylitis - a systematic comparison of conventional x- rays with magnetic resonance imaging (MRI) using established and new scoring systems.
Ann Rheum Dis 2004;63 :1046-1055

 
2004  

Maini RN, Breedveld FC, Kalden JR, Smolen JS, Furst D, Weisman MH, St Clair EW, Keenan GF, van der Heijde D, Marsters PA, Lipsky PE; Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.
Arthritis Rheum 2004;50(4):1051-65.

 
2004  

Wanders A, Landewé R, Spoorenberg A, Dougados M, van der Linden S, Mielants H, van der Tempel H, van der Heijde D. What is the most appropriate radiologic scoring method for Ankylosing Spondylitis? A comparison of the available methods based on the outcome measures in rheumatology  clinical trials filter.
Arthritis Rheum 2004;50(8):2622-32

 
2004  

Welsing P, Landewé R, van Riel P, Boers M, van Gestel A, van der Linden Sj, Swinkels H, van der Heijde D. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis.
Arthritis Rheum 2004;50(7):2082-93

 
2004  

van der Heijde D. Quantification of radiological damage in inflammatory arthritis: rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Best Pract Res Clin Rheumatol 2004;18(6):847-860

 
2004  

St Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P, Keystone E, Schiff M, Kalden JR, Wang B, Dewoody K, Weiss R, Baker D. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial.
Arthritis Rheum 2004;50(11):3432-3443

 
2004  

Wanders A, Landewé R, Spoorenberg A, de Vlam K, Mielants H, Dougados M, van der Linden S, van der Heijde D. Scoring of radiographic progression in randomised clinical trials in ankylosing spondylitis: a preference for paired reading order.
Ann Rheum Dis 2004;63(12):1601-4.

 
2004  

Bruynesteyn  K, van der Heijde D, Boers M, van der Linden S, Lassere M, van der Vleuten C. The Sharp/van der Heijde method out-performed the Larsen/Scott method on the individual patient level in assessing radiographs in early rheumatoid arthritis.
J Clin Epidemiol 2004;57(5):502-12

 
     
2003  

Landewé R, Boers M, van der Heijde D. How to interpret radiologic progression in randomised clinical trial.
Rheumatology;2003;42:2-5

 
2003  

Braun J, Baraliakos X, Golder W, Brandt J, Rudwaleit M, Listing J, Bollow M, Sieper J, van der Heijde D. MRI examinations of the spine in patients with ankylosing spondylitis (AS) before and after infliximab therapy after evaluation of a new scoring system.
Arthritis Rheum 2003;48(4):1126-1136

 
2003  

Sharp J, van der Heijde D, Boers M, Boonen A, Bruynesteyn K, Emery P, Genant H, Herborn G, Jurik A, Lassere M, McQueen F, Østergaard M, Peterfy C, Rau R, Strand V, Wassenberg S, Weissman B for the Subcommittee on Healing of Erosions of the OMERACT Imaging Committee. Repair of erosions in rheumatoid arthritis does occur. Results from two studies by the OMERACT subcommittee on healing of erosions.
J Rheumatol  2003;30:5:1102-7

 
2003  

van der Heijde D, Sharp J, Rau R, Strand V on behalf of subcommittee on healing of erosions of the OMERACT imaging committee. OMERACT Workshop: Repair of structural damage in rheumatoid arthritis.
J Rheumatol 2003;30(5):1108-9

 
2003  

Landewé RB, van der Heijde, D. Is radiographic progression a realistic outcome measure in clinical trials with early inflammatory arthritis?
Clin Exp Rheum 2003;21(suppl. 31):S37-S41

 
2003  

van der Heijde D, Landewé R. Imaging: Do erosions heal?
Ann Rheum Dis 2003;62(suppl.II):ii10-12

 
     
2002  

van der Heijde D, Simon L, Smolen J, Strand V, Sharp J, Boers M, Breedveld F, Weissmann M, Weinblatt M, Rau R, Lipsky P. How to report radiographic data in randomized clinical trials in rheumatoid arthritis? Guidelines from a roundtable discussion.
Arthritis Rheum 2002;47:215-8

 
2002  

Landewé R, Boers M, Verhoeven A, Westhovens R, van de Laar M, Markusse H, van Denderen C, Westedt M, Peeters A, Dijkmans B, Jacobs P, Boonen A, van der Heijde D, van der Linden S. COBRA-combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention.
Arthritis Rheum 2002;2:347-56

 
2002  

Bruynesteyn K, van der Heijde D, Boers M, Saudan A, Peloso P, Paulus H, Houben H, Griffiths B, Edmonds J, Bresnihan B, Boonen A, van der Linden Sj. Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference.
Arthritis Rheum 2002;46:913-20

 
2002  

van der Heijde D. Structural damage in rheumatoid arthritis as visualized through radiographs.
Arthritis Research 2002; 4 (suppl 2): S29-S33

 
2002  

Boers M, van der Heijde D. Prevention or retardation of joint damage in rheumatoid arthritis. Issues of definition, evaluation and interpretation of plain radiographs.
Drugs 2002;62:1717-24

 
2002  

Bruynesteyn K, van der Heijde D, Boers M, Verhoeven A, Boonen A, van der Linden S. Contribution of progression of erosive damage in previously eroded joints in early rheumatoid arthritis trials: COBRA trial as an example.                  Arthritis Rheum 2002;47:532-6

 
2002  

Strand V, Landewé R, van der Heijde D. Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis.
Ann Rheum Dis 2002;61(supll II):ii64-ii66

 
2002  

Bruynesteyn K, van der Heijde D, Boers M, Saudan A, Peloso P, Paulus H, Houben H, Griffiths B, Edmonds J, Bresnihan B, Boonen A, van der Linden Sj. Detecting radiological changes in rheumatoid arthritis that are considered important by clinical experts: Influence of reading with or without known sequence.
J Rheumatol 2002;29(11):2306-12

 
     
2001  

Bruynesteyn K, van der Heijde D, Boers M, Lassere M, Boonen A, Edmonds J, Houben H, Paulus H, Peloso P, Saudan A, van der Linden Sj. Minimal clinically important difference in radiological progression of joint damage over 1 year in RA: Preliminary results of a validation study with clinical experts.
J Rheumatol 2001;28:904-910

 
2001  

Lassere M, van der Heijde D, Johnson K, Bruynesteyn K, Molenaar E, Boonen A, Verhoeven A, Emery P, Boers M. Robustness and generalisability of smallest detectable difference in radiological progression.
J Rheumatol 2001:28:911-3

 
2001  

Lassere M, van der Heijde D, Johnson KR, Boers M, Edmonds J. Reliability of measures of disease activity and disease damage in RA: Implications for the smallest detectable difference, the minimum clinical important difference, and analysis of treatment effects in randomized controlled trials.
J Rheumatol 2001;28:892-903

 
2001  

van der Heijde D, Lassere M, Edmonds J, Kirwan J, Strand V, Boers M for the OMERACT imaging task force. Minimal Clinically Important Difference in plain films in RA: group discussions, conclusions and recommendations.
J Rheumatol 2001;28:914-5

 
2001  

van der Heijde D. Radiographic assessment of joint disease in rheumatoid arthritis. Joint damage occurs early in the disease course.
J Musculoskeletal Med 2001;5 (suppl):S15-S20

 
2001  

van der Heijde D. Radiographic progression in rheumatoid arthritis: does it reflect outcome? Does it reflect therapy?
Ann Rheum Dis 2001;60:iii47-iii50

 
2001  

van der Heijde D. Aspects of the radiological evaluation of rheumatoid arthritis.
Ann Med Interne 2001; 152: 518-21

 
     
2000  

van der Heijde D. How to read radiographs according to the Sharp|van der Heijde method.
J Rheumatol 2000;27:261-3

 
2000  

van der Heijde DMFM. Radiographic imaging: The “gold standard” for assessment of disease progression in rheumatoid arthritis.                   
Rheumatology 2000;39(suppl 1):9-16

 
2000  

Proudman SM, Conaghan PG, Richardson C, Green MJ, McGonagle D, Wakefield RJ, Griffiths B, Reece R, Miles S, Veale D, Martin M, Huston G, Gough A, Adebajo A, Helliwell P, van der Heijde D, Emery P. Treatment of poor-prognosis early rheumatoid arthritis: A randomized study of treatment with methotrexate, cyclosporin A and intraarticular corticosteroids compared with sulfasalazine alone.
Arthritis and Rheum 2000;43:1809-19

 
2000  

Hulsmans HMJ, Jacobs JWG, van der Heijde D, van Albada-Kuipers GA, Schenk Y, Bijlsma JWJ. Course of radiological damage during the first 6 years of rheumatoid arthritis.
Arthritis Rheum 2000;43:1927-40

 
2000  

Lipsky P, van der Heijde D, St. Clair EW, Furst DE, Breedveld F, Kalden JR, Smolen J, Weisman M, Emery P, Feldmann M, Harriman GR, Maini R for the Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Infliximab and methotrexate in the treatment of rheumatoid arthritis.
New Eng J Med 2000;343:1594-1602

 
     
1999  

van der Heijde D, Boers M, Lassere M. Methodological issues in radiographic scoring methods in RA.
J Rheumatol 1999;26:726-30

 
1999  

van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method.
J Rheumatol 1999;743-5

 
1999  

Molenaar E, Edmonds J, Saudan A, Lassere M, Boers M, van der Heijde D. A practical exercise in reading RA radiographs by the Larsen and Sharp methods.
J Rheumatol 1999;26:746-8

 
1999  

van der Heijde D, Boonen A, Boers M, Kostense P, van der Linden S. Reading radiographs in chronological order, in pairs or as single films has important implications for the discriminative power of rheumatoid arthritis clinical trials
Rheumatology 1999;38:1213-20

 
1999  

van der Heijde D, Dankert T, Nieman F, Rau R, Boers M. Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis
Rheumatology 1999;38:941-7

 
     
1997  

Boers M, Verhoeven A, Markusse H, van de Laar M, Westhovens R, van Denderen C, van Zeben J, Dijkmans B, Peeters A, Jacobs P, van den Brink H, Schouten H, van der Heijde D, Boonen A, van der Linden Sj. Combination of step-down corticosteroids, methotrexate and sulfasalazine, compared to sulfasalazine alone in early, active rheumatoid arthritis produces excellent 1-year disease control and low toxicity; the COBRA trial.
Lancet 1997;350:309-18

 
       
1996  

van der Heijde DMFM. Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability. In: Bailliere Clin Rheum. Modern imaging techniques. Part I: Traditional Methods. Bird HA and Dougados M [eds.].
Bailliere Tindall, London, 1996;10:435-53

 
       
1995  

van der Heijde DMFM,  van Leeuwen MA, van Riel PLCM, van de Putte LBA. Radiographic progression on X-rays of hands and feet during the first three years of rheumatoid arthritis measured according to Sharp's method [van der Heijde modification]
J Rheumatol 1995;22:1792-6

 
1995  

van der Heijde DMFM. Joint erosions and patients with early rheumatoid arthritis.
Br J Rheumatol 1995;34[suppl]:74-8

 
       
1992  

van der Heijde DMFM, van Leeuwen MA, van Riel PLCM, Koster AM, van 't Hof MA,  van Rijswijk MH, van de Putte LBA. Biannual radiographic assessments of hands and feet in a three‑year prospective followup of patients with early rheumatoid arthritis.
Arthritis Rheum 1992;35:26-34

 
     
1989  

van der Heijde DMFM, van Riel PLCM, Nuver‑Zwart HH, Gribnau FWJ, van de Putte LBA. Effects of hydroxychloroquine and sulfasalazine on progression of joint damage in rheumatoid arthritis.
Lancet 1989;I:1036‑8

 
 

 

.


chapters in books in relation to imaging

 

 

2008  

van der Heijde D.
Outcome assessment of rheumatoid arthritis. Radiography.

In: Rheumatoid Arthritis. Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (editors) Mosby Elsevier, Philadelphia 2008;260-6

 
       
2008  

Baratelle A, van der Heijde D.
Radiographic imaging end points in rheumatoid arthritis trials.
In: Clinical trials in rheumatoid arthritis and osteoarthritis. D. Reid, C. Miller (editors) Springer-Verlag London 2008:201-22

 
       
2005  

van der Heijde D.
Radiological measurements of periarticular bone loss, erosions, and joint space: x-ray measurement of erosions and joint space narrowing.
In: Bone Disease in Rheumatology. M. Maricic, O. Gluck (editors), Lippincott, Williams & Wilkins,  Philadelphia, 2005:53-58

 
       
2004  

van der Heijde D.
Measurement of Radiological Outcomes.
In: Rheumatoid Arthritis. St. Clair E. W, Pisetsky D, Haynes B.F. (editors), Lippincott Williams & Wilkins, Philadelphia, 2004, 90-97

 
       
1995  

van der Heijde DMFM.
Radiographs as an outcome measure in rheumatoid arthritis.
Rheumatology in Europe 1995;24(suppl 2):127-8

 
       
1993  

van de Putte LBA, van Riel PLCM, Boerbooms AMTh, van der Heijde DMFM, Jeurissen MEC. DMARDs: do they retard progression of radiological joint damage in rheumatoid arthritis? Eular Publishers, 1993

 
       
1992  

van de Putte LBA, van der Heijde DMFM, van Riel PLCM.
Sulfasalazin‑Behandlung und radiologische Gelenkschädigung bei Polyarthritis.
In: Wagenhäuser FJ, ed. Salazopyrin EN ‑ Standortbestimmung und Ausblick. Eular Publishers, 1992

 
 
 

print version